Breaking News

Matica breaks ground on GMP virus production facility

The CDMO has begun construction on a 25,000 sqft facility for GMP virus production suites, development laboratories and ...

Malvern Panalytical launches compact X-ray diffractometer

The device is hoped to enable smaller companies and educational institutions to contribute to research and process ...

CatSci invests in material and analytical science

The company has also appointed two director roles to lead its expansion plans

Shoring up the pharma supply chain in 2021 and beyond

As a result of the ongoing pandemic, the pharmaceutical supply chain has faced undeniable pressure. Amid a deluge of ...

SB3000 awarded grant for continuous manufacturing technology

The μLOT technology can reportedly reduce the environmental impact of medicine production and ensure consistent ...

Almac Group invests $7.1 m in R&D centre

The next phase of development is currently underway with further announcements expected in the coming months, the ...

Plastic pallets and the COVID response

Jim Hardisty explores the logistical challenges of distributing the COVID vaccine, how Goplasticpallets.com has been ...

Catalent to acquire Delphi Genetics and launch plasmid manufacturing in US

Upon completion, all of Delphi’s team will transfer to Catalent’s cell and gene therapy business

Novo to acquire drug development services provider Altasciences

Altasciences’ executive management team, led by CEO Chris Perkin, will continue to lead the business following the ...

Space travel puts mitochondria’s central role in the spotlight

The scientific community has long validated the significance of mitochondria as our cell’s “energy factories.” ...

Derisking topical formulation development with multifactorial disease models

Today’s market for topical pharmaceuticals is valued at around $95 billion, with development efforts focused on small ...

Expanding the medicinal chemist’s toolbox

Ray Boffey, Executive Director of Medicines Research at Domainex, explains the applications and benefits of fragment- ...

Intravacc leads consortium on Dutch multi-purpose vaccine plant

It has also built a pilot production plant at Utrecht Science Park over the past 24 months

MaxiVAX and Minaris enter partnership for cancer immunotherapy

Minaris will be responsible for the manufacturing, freezing and shipping of the MVX-ONCO-2 capsules, which will be ...

Inspiration and Learning

People

Reports